Prefilled Syringe Market to Reach $28,527.2 Million in 2035, Growing at 8.1% CAGR

Prefilled Syringe market valued at $13,185.9 million in 2025 and is projected to reach $28,527.2 million by 2035, growing at a CAGR of 8.1% during the forecast period (2026-2035). The market comprises ready-to-use drug delivery systems designed to improve dosing accuracy, safety, and convenience across a wide range of therapeutic applications. The market is witnessing strong global growth driven by the rising prevalence of chronic diseases, increasing adoption of biologics, and growing demand for self-administration devices. Expansion is further supported by the shift toward patient-centric drug delivery, reduction of medication errors, and improved sterility compared to conventional vial-and-syringe formats. Pharmaceutical and biotechnology companies are increasingly integrating prefilled syringe formats into product pipelines, particularly for monoclonal antibodies, insulin, and emergency therapies. Technological advancements in polymer-based syringes, dual-chamber systems for lyophilized drugs, and safety-engineered devices are further accelerating market expansion.

Browse the full report description of “Prefilled Syringe Market Size, Share & Trends Analysis Report by Material (Glass Based, and Plastic Based) By Design (Single Chamber, Double Chamber, and Customized) By Application (Arthritis, Anaphylaxis, Ophthalmology, Diabetes, Cancer and Others) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/prefilled-syringe-market

According to global health organizations and industry data, the increasing burden of chronic diseases such as diabetes, rheumatoid arthritis, and cancer combined with the rising use of injectable biologics—has significantly strengthened the demand for advanced drug delivery systems, including prefilled syringes. Large-scale healthcare datasets and treatment adoption trends are playing a critical role in forecasting demand, optimizing manufacturing capacity, and ensuring efficient drug delivery globally.

Key Statistics: Prefilled Syringe at a Glance

• Prefilled syringes are widely used in the administration of over 50% of biologic drugs, reflecting their growing importance in advanced therapeutics.
• More than 463 million people globally are living with diabetes, a key application area driving demand for prefilled insulin delivery systems.
• Chronic diseases account for over 70% of global deaths, significantly increasing reliance on injectable treatments and prefilled syringe technologies.

Key Innovators Driving Prefilled Syringe Transformation

The key players in the prefilled syringe market include Becton, Dickinson and Company, Gerresheimer AG, SCHOTT AG, Stevanato Group S.p.A., West Pharmaceutical Services, Inc, among others.

• In June 2025, Gerresheimer AG expanded its portfolio of containment solutions with glass and polymer-based prefilled syringe systems designed for biologic drugs and product stability.
• In April 2025, Becton, Dickinson and Company introduced a prefilled syringe platform with safety mechanisms and compatibility with a range of injectable therapies.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Material
  • By Design
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Becton, Dickinson and Company, Gerresheimer AG, SCHOTT AG, Stevanato Group S.p.A., West Pharmaceutical Services, Inc, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Prefilled Syringe Market Report Segment

By Material

• Glass Based
• Plastic Based

By Design

• Single Chamber
• Double Chamber
• Customized

By Application

• Arthritis
• Anaphylaxis
• Ophthalmology
• Diabetes
• Cancer
• Others

Global Prefilled Syringe Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/prefilled-syringe-market